# A Study of JNJ-78306358 in Participants With Advanced Stage Solid Tumors

> **NCT04991740** · PHASE1 · COMPLETED · sponsor: **Janssen Research & Development, LLC** · enrollment: 39 (actual)

## Conditions studied

- Neoplasms

## Interventions

- **DRUG:** JNJ-78306358

## Key facts

- **NCT ID:** NCT04991740
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-10-24
- **Primary completion:** 2023-02-09
- **Final completion:** 2023-02-09
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2023-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04991740

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04991740, "A Study of JNJ-78306358 in Participants With Advanced Stage Solid Tumors". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT04991740. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*